Affiliation:
1. N.N. Petrov National Medical Research Center of Oncology;
I.P. Pavlov First Saint Petersburg State Medical University
2. I.P. Pavlov First Saint Petersburg State Medical University;
I.I. Mechnikov North-Western State Medical University
3. N.N. Petrov National Medical Research Center of Oncology;
I.I. Mechnikov North-Western State Medical University
4. N.N. Petrov National Medical Research Center of Oncology
Abstract
Background. Various tumor control genes and microRNAs (miRNa) play an important role in the development and progression of colorectal cancer (CRC). the expression of these genes can differ significantly in tumor and adjacent healthy tissues. there is no exact data at what distance from the tumor the adjacent healthy tissue is located in terms of gene expression.The aim of the investigation was to study the tumor control genes (E2F3, TGFB, NFKB, KLF-12, EGFR and MMP9), as well as the microRNA genes (microRNA-15, -16, -21 and -210) expression profiles in tumor and adjacent healthy tissues.Material and methods. the study included 19 patients diagnosed with colorectal cancer. the tumor control genes (E2F3, TGFB, NFKB, KLF-12, EGFR and MMP9), as well as the miRNA genes (miRNA-15, -16, -21 and -210) expression levels were investigated in tumor and adjacent normal tissue samples taken during colonoscopy.Results. a decrease in the level of expression of E2F3 (median 3,73, Q1-Q3 2,64 Reu vs. median 6.5, Q1-Q3 6,39 REU, p=0,01) and miRNA-16 (median 2,83, Q1-Q3 4,74 REU vs. median 4,29, Q1-Q3 3,73 REU, p=0,027) and an increase in the expression level of miRNA-21 (median 2,64, Q1-Q3 1,38 REU vs. median 1,41, Q1-Q3 1,21 REU, p<0,001) were found in tumor tissue compared to normal tissue of patients with CRC.Conclusion. significant differences in the E2F3, miRNA-16 and miRNA-21 gene expressions were revealed. an increased level of E2F3 and miRNA-16 expressions at a distance of 1–2 cm from the tumor may be a predictor of tumor recurrence and progression, and an increased miRNA-21 expression in tumor tissue as compared to adjacent tissue may be a negative prognostic factor. this information can be used in further clinical research.
Publisher
Tomsk Cancer Research Institute
Reference30 articles.
1. Kaprin A.D. Clinical guidelines. Malignant neoplasms of the colon and rectosigmoid region. All-Russian National Union. Association of Oncologists of Russia; 2020. (in Russian).
2. Kaprin A.D. Clinical guidelines. Rectal cancer. All-Russian National Union Association of Oncologists of Russia; 2020. (in Russian).
3. Bujko K., Rutkowski A., Chang G.J., Michalski W., Chmielik E., Kusnierz J. Is the 1-cm rule of distal bowel resection margin in rectal cancer based on clinical evidence? A systematic review. Ann Surg Oncol. 2012; 19(3): 801–8. doi: 10.1245/s10434-011-2035-2.
4. Ker C.-G. Surgical safety margin of gastroenterological cancer surgery: A truth or a dream? Formosan J Sur. 2014; 47(3): 83–9.
5. Aran D., Camarda R., Odegaard J., Paik H., Oskotsky B., Krings G., Goga A., Sirota M., Butte A.J. Comprehensive analysis of normal adjacent to tumor transcriptomes. Nat Commun. 2017; 8(1): 1077. doi: 10.1038/s41467-017-01027-z.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献